As of 2025-12-15, the EV/EBITDA ratio of Asensus Surgical Inc (ASXC) is -1.17. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ASXC's latest enterprise value is 87.93 mil USD. ASXC's TTM EBITDA according to its financial statements is -75.08 mil USD. Dividing these 2 quantities gives us the above ASXC EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 18.5x - 23.1x | 20.7x |
| Forward P/E multiples | 23.0x - 26.8x | 24.9x |
| Fair Price | (6.30) - (6.34) | (6.25) |
| Upside | -1910.2% - -1921.3% | -1896.0% |
| Date | EV/EBITDA |